Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group.
Ochiai
T
T
Dept of Surgery, School of Medicine, Chiba University, Japan.
Fukao
K
K
Takahashi
K
K
Endo
T
T
Oshima
S
S
Uchida
K
K
Yokoyama
I
I
Ishibashi
M
M
Takahara
S
S
Iwasaki
Y
Y
D001424:Bacterial Infections / Q000453:epidemiology; D001794:Blood Pressure; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D009181:Mycoses / Q000453:epidemiology; D018579:Patient Selection; D011183:Postoperative Complications / Q000453:epidemiology; D011239:Prednisolone / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors; D014777:Virus Diseases / Q000453:epidemiology
D016572:Cyclosporine; D011239:Prednisolone; D016559:Tacrolimus